CONSTANT LEVERAGE SHORT - META PLATFORMS A Stock

Certificat

P74JB

FRBNPP0593U5

Market Closed - Euronext Paris 12:30:02 2024-05-21 EDT
0.017 EUR +6.25% Intraday chart for CONSTANT LEVERAGE SHORT - META PLATFORMS A
3 months-15.00%
6 months-79.01%
Date Price Change
24-05-21 0.017 +6.25%
24-05-20 0.016 0.00%
24-05-17 0.016 0.00%
24-05-16 0.016 0.00%
24-05-15 0.016 -5.88%

Real-time Euronext Paris

Last update May 21, 2024 at 12:30 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying META PLATFORMS, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
P74JB
ISINFRBNPP0593U5
Date issued 2023-01-05
Maturity Unlimited
Parity 1 : 1
Emission price 4.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.9
Lowest since issue 0.011
Spread 0.001
Spread %5.56%

Company Profile

Meta Platforms, Inc. specializes in online social networking services. Net sales break down by activity as follows: - operation of social networking, messaging, photo and video sharing platforms (98.6%): operation of the Facebook, Instagram, Messenger, Threads and WhatsApp platforms (3.98 billion monthly active users in 2023) ; - sale of virtual and augmented reality products, software and devices (1.4%): virtual reality headsets (Meta Quest), connected screens (Facebook Portal), wearable devices, etc. Net sales break down by source of income into advertising spaces (97.5%) and other (2.2%). Net sales are distributed geographically as follows: the United States and Canada (39.2%), Asia-Pacific (26.8%), Europe (23.1%) and other (10.9%).
Sector
-
More about the company

Ratings for Meta Platforms, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Meta Platforms, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
62
Last Close Price
468.8 USD
Average target price
520.5 USD
Spread / Average Target
+11.01%
Consensus
  1. Stock Market
  2. Certificates
  3. P74JB Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW